Genesys International Corporation Limited Increases Authorized Share Capital to Rs. 45 Crores
Genesys International Corporation Limited has approved a significant 65% increase in its authorized share capital from Rs. 27.25 crores to Rs. 45 crores during a board meeting held on April 23, 2026. The expansion involves creating 3.55 crore additional equity shares of Rs. 5 face value each, bringing the total authorized shares to 9 crore. The company will seek shareholder approval through a postal ballot and has notified both BSE and NSE of this strategic capital enhancement decision.

*this image is generated using AI for illustrative purposes only.
Genesys International Corporation Limited has announced a significant expansion of its authorized share capital, marking a strategic move to enhance its financial capacity. The decision was formalized during a board meeting held on April 23, 2026, demonstrating the company's commitment to strengthening its capital structure.
Board Resolution Details
The board of directors convened on April 23, 2026, from 4:30 p.m. to 5:15 p.m., where they discussed and approved key resolutions regarding the company's capital expansion. The meeting focused on two primary agenda items: the increase in authorized share capital and the issuance of a postal ballot notice for shareholder approval.
Authorized Share Capital Enhancement
The company has approved a substantial increase in its authorized share capital structure, representing a significant expansion of its financial framework.
| Parameter: | Current Structure | Proposed Structure |
|---|---|---|
| Authorized Capital: | Rs. 27,25,00,000 | Rs. 45,00,00,000 |
| Total Equity Shares: | 5,45,00,000 shares | 9,00,00,000 shares |
| Face Value per Share: | Rs. 5 | Rs. 5 |
| Additional Shares Created: | - | 3,55,00,000 shares |
The expansion involves creating 3,55,00,000 additional equity shares of face value Rs. 5 each, which will rank pari-passu in all respects with the existing equity shares of the company. This increase represents approximately a 65% expansion from the current authorized capital base.
Regulatory Compliance and Documentation
As part of the capital restructuring process, the company will implement consequential amendments to the share capital clause of its Memorandum of Association. The board has also approved the issuance of a postal ballot notice to seek shareholder approval for these changes, ensuring compliance with regulatory requirements under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Corporate Communication
The company has formally communicated this development to both major stock exchanges where its shares are listed. The notification was sent to BSE Limited (Scrip Code: 506109) and National Stock Exchange of India Ltd. (Symbol: GENESYS), fulfilling the disclosure obligations under Regulation 30 of the listing regulations. Company Secretary and Compliance Officer Kushal Jain signed the official communication, ensuring proper corporate governance protocols were followed throughout the process.
Historical Stock Returns for Genesys International Corp
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.60% | +8.39% | +13.51% | -47.63% | -60.08% | +210.91% |
What specific growth initiatives or acquisitions is Genesys planning to fund with the expanded share capital?
How might this 65% capital expansion impact the company's debt-to-equity ratio and overall financial leverage strategy?
Will the additional 3.55 crore shares be issued through a rights offering, private placement, or public issue to existing shareholders?


































